Guardion Health Sciences, Inc. (GHSI): Price and Financial Metrics


Guardion Health Sciences, Inc. (GHSI): $1.03

-0.10 (-8.85%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GHSI to Watchlist
Sign Up

Industry: Consumer Goods


Ranked

of 71

in industry

GHSI POWR Grades


  • GHSI scores best on the Momentum dimension, with a Momentum rank ahead of 39% of US stocks.
  • GHSI's strongest trending metric is Growth; it's been moving down over the last 45 weeks.
  • GHSI ranks lowest in Stability; there it ranks in the 2nd percentile.

GHSI Stock Summary

  • With a market capitalization of $26,869,692, Guardion Health Sciences Inc has a greater market value than just 3.75% of US stocks.
  • As for revenue growth, note that GHSI's revenue has grown 149.24% over the past 12 months; that beats the revenue growth of 95.11% of US companies in our set.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for GHSI comes in at -141.9% -- higher than that of just 1.73% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Guardion Health Sciences Inc are MNSB, IDXG, SUNW, MYO, and ACBI.
  • GHSI's SEC filings can be seen here. And to visit Guardion Health Sciences Inc's official web site, go to www.guardionhealth.com.

GHSI Valuation Summary

  • GHSI's price/sales ratio is 17.2; this is 51.54% higher than that of the median Healthcare stock.
  • GHSI's price/earnings ratio has moved up 7.1 over the prior 29 months.
  • GHSI's price/sales ratio has moved down 63.2 over the prior 29 months.

Below are key valuation metrics over time for GHSI.

Stock Date P/S P/B P/E EV/EBIT
GHSI 2021-08-31 17.2 0.8 -2.6 -2.2
GHSI 2021-08-30 16.9 0.8 -2.5 -2.1
GHSI 2021-08-27 17.4 0.8 -2.6 -2.2
GHSI 2021-08-26 17.7 0.9 -2.7 -2.2
GHSI 2021-08-25 17.3 0.8 -2.6 -2.2
GHSI 2021-08-24 18.3 0.9 -2.7 -2.3

GHSI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • GHSI has a Quality Grade of D, ranking ahead of 6.18% of graded US stocks.
  • GHSI's asset turnover comes in at 0.071 -- ranking 291st of 677 Pharmaceutical Products stocks.
  • PBH, TXMD, and NVS are the stocks whose asset turnover ratios are most correlated with GHSI.

The table below shows GHSI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.071 -0.042 -3.780
2021-03-31 0.093 -0.050 -7.284
2020-12-31 0.147 -0.030 -5.816
2020-09-30 0.142 0.509 -5.190
2020-06-30 0.144 0.507 -5.304
2020-03-31 0.085 0.606 -6.883

GHSI Stock Price Chart Interactive Chart >

Price chart for GHSI

GHSI Price/Volume Stats

Current price $1.03 52-week high $8.40
Prev. close $1.13 52-week low $0.96
Day low $1.03 Volume 433,242
Day high $1.11 Avg. volume 2,191,287
50-day MA $1.20 Dividend yield N/A
200-day MA $1.76 Market Cap 25.16M

Guardion Health Sciences, Inc. (GHSI) Company Bio


Guardion Health Sciences, Inc. provides health care services. It offers, Lumega-Z a medical food formulated to replenish and restore the macular protective pigment. The firm also develops medical devices that measures macular pigment density. The company was founded by Michael Favish in 2009 and is headquartered in San Diego, CA.


GHSI Latest News Stream


Event/Time News Detail
Loading, please wait...

GHSI Latest Social Stream


Loading social stream, please wait...

View Full GHSI Social Stream

Latest GHSI News From Around the Web

Below are the latest news stories about Guardion Health Sciences Inc that investors may wish to consider to help them evaluate GHSI as an investment opportunity.

Guardion Health Sciences Announces Financial Results for the Three Months Ended September 30, 2021

$3,000,000+ Sales from Viactiv® Products During the QuarterHOUSTON, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements and medical devices, announced its financial results for the three months and nine months ended September 30, 2021. The Company also provided a corporate update to shareholders. Financial highlights for

Yahoo | November 10, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning, investor!

William White on InvestorPlace | October 28, 2021

GHSI Stock: 12 Things to Know About Guardion Health Science as Shares Rocket

Guardion Health Science (GHSI) stock is taking off on Wednesday thanks to a presentation taking place today and heavy trading.

William White on InvestorPlace | October 27, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Good morning, trader!

William White on InvestorPlace | October 27, 2021

Guardion Health Sciences to Present at the Benzinga Global Small Cap Conference

HOUSTON, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, announces today that Chief Executive Officer Bret Scholtes will present a corporate overview at the Benzinga Global Small Cap Conference, which is being held virtually on October 27 – 28, 2021. Mr. Scholtes will deliver his corporate presen

Yahoo | October 25, 2021

Read More 'GHSI' Stories Here

GHSI Price Returns

1-mo -33.55%
3-mo -16.94%
6-mo -36.02%
1-year -29.82%
3-year N/A
5-year N/A
YTD -58.63%
2020 88.38%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9289 seconds.